GSK945237
Sponsors
GlaxoSmithKline
Conditions
Healthy SubjectsInfections, Bacterial
Phase 1
To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects
CompletedNCT00517673
Start: 2007-07-31End: 2008-09-30Updated: 2012-03-19
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
WithdrawnNCT01039610
Start: 2009-11-30End: 2010-08-31Updated: 2015-04-22